Printer Friendly

COMPANY INFORMATION
Cardiome Pharma Corp. 600-6190 Agronomy Rd Vancouver, BC V6T 1Z3 Tel: (604) 677-6905 Toll-free: (800) 330-9928 Fax: (604) 677-6915 Contact Name Peter K. Hofman Industry Pharmaceuticals		Key Executives Douglas G. Janzen, CEO Curtis M. Sikorsky, CFO Researches and develops proprietary drugs to treat or prevent cardiovascular diseases, focusing on treatment of atrial fibrillation.
FP ADVISOR COVERAGE Cardiome Pharma Corp. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/COM Nasdaq/CRME $5.49 $6.05 $3.22 n.a. n.a. n.a. 1.06 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 87,184 n.a. $-0.35 Sept. 30/09 -8.19% -25.67% -11.72% $330,300
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 1,604 4,879 20,668 Net income (60,520) (85,487) (36,147) Total assets 63,137 101,245 68,591 $ $ $ Earnings per share* (0.95) (1.36) (0.68) % % % Return on equity (112.03) (126.14) (56.45)   * Common
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09 Sept. 30/08 $000s $000s Operating revenue 30,325 2,304 Net income (22,758) (77,284) $ $ Earnings per share (0.35) (1.21)

COMPANY NEWS

Results for 'Cardiome Pharma Corp.' from past 30 days: 1 hit. Labopharm may be the win Canada's biotech sector needs; 'Great keypoint' National Post - Fri Feb 5 2010 - 558 words (Links are to articles.)